Show simple item record

dc.creatorSinha, Gunjanen
dc.date.accessioned2011-07-12T18:19:56Zen
dc.date.available2011-07-12T18:19:56Zen
dc.date.created2006-09en
dc.date.issued2006-09en
dc.identifier.bibliographicCitationNature Medicine 2006 September; 12(9): 983en
dc.identifier.urihttp://xr8el9yb8v.search.serialssolutions.com/?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Drug+companies+accused+of+stalling+tailored+therapies&title=Nature+Medicine&volume=12&issue=9&date=20060900&au=Sinha,+Gunjanen
dc.identifier.urihttp://hdl.handle.net/10822/509518en
dc.descriptionnewsen
dc.formatNews Articleen
dc.languageengen
dc.source299164en
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationGenetics, Molecular Biology and Microbiologyen
dc.titleDrug companies accused of stalling tailored therapiesen
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2018 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885